| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
8 companies
Heron Patrick J is a Director, 10% Owner at MBX with holdings across 8 companies. Recent SEC Form 4 filings include 8 buys and 0 sells.
Estimated insider holdings value: $324.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2020 | PASG Passage Bio, Inc. | Director, 10% Owner | Buy | 550,000 | $18.00 | $9,900,000.00 | +12.3% | |
| Feb 4, 2020 | ARQT Arcutis Biotherapeutics, Inc. | Director, 10% Owner | Buy | 500,000 | $17.00 | $8,500,000.00 | +5.0% | |
| Jul 22, 2019 | MIRM Mirum Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 450,000 | $15.00 | $6,750,000.00 | +14.4% | |
| May 30, 2018 | ITRM Iterum Therapeutics Plc | Director, 10% Owner | Buy | 456,099 | $13.00 | $5,929,287.00 | +42.1% | |
| May 12, 2015 | COLL Collegium Pharmaceutical, Inc | Director, 10% Owner | Buy | 150,000 | $12.00 | $1,800,000.00 | +8.6% | |
| Apr 20, 2015 | Director | Buy | 200,000 | $16.00 | $3,200,000.00 | New |